Secondary prevention for ischemic heart disease. Relative numbers needed to treat with different therapies.
about
Disease impact number and population impact number: population perspectives to measures of risk and benefitCalculating the number needed to treat for trials where the outcome is time to an eventClinical and public health assessment of benefits and risks of statins in primary prevention of coronary events: resolved and unresolved issues.Confidence intervals for the number needed to treat.Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals.
P2860
Secondary prevention for ischemic heart disease. Relative numbers needed to treat with different therapies.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
1997年论文
@zh
1997年论文
@zh-cn
name
Secondary prevention for ische ...... reat with different therapies.
@en
type
label
Secondary prevention for ische ...... reat with different therapies.
@en
prefLabel
Secondary prevention for ische ...... reat with different therapies.
@en
P1476
Secondary prevention for ische ...... reat with different therapies.
@en
P2093
P304
P356
10.1001/ARCHINTE.157.18.2045
P407
P577
1997-10-01T00:00:00Z